Inventor · disambiguated record
John M. Reno
Also filed as: RENO JOHN · RENO JOHN M
46 granted patents·13 pending applications·3,530 citations·filing 1984–2013
99Inventor score
Files withNEORX CORP44ALETHEON PHARMACEUTICALS INC2PERLAN THERAPEUTICS INC2PONIARD PHARMACEUTICALS INC2DOW CHEMICAL CO1
Top patents by PatentIndex Score
59 records- 0199US6720350B2Therapeutic inhibitor of vascular smooth muscle cellsSCIMED LIFE SYSTEMS INC·Filed 2002·Granted Apr 13, 2004·204 cites·40 claims
- 0299US6663881B2Therapeutic inhibitor of vascular smooth muscle cellsNEORX CORP·Filed 2001·Granted Dec 16, 2003·178 cites·13 claims
- 0399US6569441B2Therapeutic inhibitor of vascular smooth muscle cellsNEORX CORP·Filed 2001·Granted May 27, 2003·213 cites·10 claims
- 0499US6491938B2Therapeutic inhibitor of vascular smooth muscle cellsNEORX CORP·Filed 2001·Granted Dec 10, 2002·166 cites·18 claims
- 0599US5981568ATherapeutic inhibitor of vascular smooth muscle cellsNEORX CORP·Filed 1997·Granted Nov 9, 1999·682 cites·56 claims
- 0698US5811447ATherapeutic inhibitor of vascular smooth muscle cellsNEORX CORP·Filed 1995·Granted Sep 22, 1998·402 cites·18 claims
- 0797US6306421B1Therapeutic inhibitor of vascular smooth muscle cellsNEORX CORP·Filed 1997·Granted Oct 23, 2001·227 cites·36 claims
- 0896US6358989B1Therapeutic inhibitor of vascular smooth muscle cellsNEORX CORP·Filed 1999·Granted Mar 19, 2002·135 cites·20 claims
- 0993US5106951AAntibody conjugatesNEORX CORP·Filed 1989·Granted Apr 21, 1992·133 cites·12 claims
- 1090US6416738B1Pretargeting methods and compoundsNEORX CORP·Filed 2000·Granted Jul 9, 2002·32 cites·20 claims
- 1190US5608060ABiotinidase-resistant biotin-DOTA conjugatesNEORX CORP·Filed 1993·Granted Mar 4, 1997·100 cites·9 claims
- 1287US5968477ARadiolabeled annexin conjugates with hexose and a chelatorNEORX CORP·Filed 1996·Granted Oct 19, 1999·38 cites·21 claims
- 1387US5217705AMethod of diagnosing blood clots using fibrin-binding proteinsNEORX CORP·Filed 1988·Granted Jun 8, 1993·120 cites·11 claims
- 1485US6358710B1Humanized antibodies that bind to the antigen bound by antibody NR-LU-13NEORX CORP·Filed 1997·Granted Mar 19, 2002·59 cites·7 claims
- 1585US6171577B1Radiolabeled annexinsNEORX CORP·Filed 1999·Granted Jan 9, 2001·33 cites·14 claims
- 1685US6015897ABiotinamido-n-methylglycyl-seryl-o-succinamido-benzyl dotaNEORX CORP·Filed 1996·Granted Jan 18, 2000·69 cites·1 claims
- 1785US5976535APretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful thereforeNEORX CORP·Filed 1995·Granted Nov 2, 1999·76 cites·3 claims
- 1883US7144991B2Streptavidin expressed gene fusions and methods of use thereofALETHEON PHARMACEUTICALS INC·Filed 2001·Granted Dec 5, 2006·33 cites·1 claims
- 1982US5283342ABiotinylated small moleculesNEORX CORP·Filed 1992·Granted Feb 1, 1994·61 cites·4 claims
- 2081US7696324B2Humanized antibodiesPERLAN THERAPEUTICS INC·Filed 2006·Granted Apr 13, 2010·7 cites·1 claims
- 2181US6709652B2Pretargeting methods and compoundsNEORX CORP·Filed 2001·Granted Mar 23, 2004·8 cites·5 claims
- 2280US5886143AHepatic-directed compounds and reagents for preparation thereofNEORX CORP·Filed 1994·Granted Mar 23, 1999·37 cites·5 claims
- 2379US5630996ATwo-step pretargeting methods using improved biotin-active agent conjugatesNEORX CORP·Filed 1993·Granted May 20, 1997·51 cites·16 claims
- 2478US7115248B2Radiolabeled annexinsNEORX CORP·Filed 2004·Granted Oct 3, 2006·5 cites·17 claims
- 2578US6677307B2TGF-α polypeptides, functional fragments and methods of use thereforKALEIDOS PHARMA INC·Filed 2002·Granted Jan 13, 2004·9 cites·5 claims
- 2678US4877868ARadionuclide antibody couplingNEORX CORP·Filed 1986·Granted Oct 31, 1989·46 cites·25 claims
- 2775US5171563ACleavable linkers for the reduction of non-target organ retention of immunoconjugatesNEORX CORP·Filed 1992·Granted Dec 15, 1992·44 cites·34 claims
- 2874US5578287AThree-step pretargeting methods using improved biotin-active agentNEORX CORP·Filed 1993·Granted Nov 26, 1996·33 cites·18 claims
- 2973US5985826AMethods of using hepatic-directed compounds in pretargeting strategiesNEORX CORP·Filed 1997·Granted Nov 16, 1999·33 cites·5 claims
- 3072US5955605ABiotinidase resistant biotin-DOTA conjugatesNEORX CORP·Filed 1996·Granted Sep 21, 1999·36 cites·10 claims
- 3172US5624896AClearing agents useful in pretargeting methodsNEORX CORP·Filed 1995·Granted Apr 29, 1997·39 cites·18 claims
- 3271US5175257ARadiolabeled proteins for diagnostic or therapeutic useNEORX CORP·Filed 1991·Granted Dec 29, 1992·29 cites·36 claims
- 3367US6024937AAromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imagingNEORX CORP·Filed 1995·Granted Feb 15, 2000·11 cites·16 claims
- 3467US5112953ARadiolabeled proteins for diagnostic or therapeutic useNEORX CORP·Filed 1989·Granted May 12, 1992·30 cites·40 claims
- 3565US7078013B2Pretargeting methods and compoundsALETHEON PHARMACEUTICALS INC·Filed 2004·Granted Jul 18, 2006·0 cites·4 claims
- 3665US4962154ALatex-antigen-antibody complexes for immunoassayDOW CHEMICAL CO·Filed 1988·Granted Oct 9, 1990·24 cites·17 claims
- 3764US6022966APretargeting methods and compoundsNEORX CORP·Filed 1993·Granted Feb 8, 2000·28 cites·14 claims
- 3864US5616690AHexose derivatized human serum albumin clearing agentsNEORX CORP·Filed 1993·Granted Apr 1, 1997·28 cites·14 claims
- 3964US2009094715A1Methods of use of antibodies with reduced immunogenicity or toxicityPONIARD PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 4063US2005100545A1Methods of use of antibodies with reduced immunogenicity or toxicityNEORX CORP·Filed 2003·Application pending·0 cites
- 4162US7744853B2Radiolabeled annexinsPONIARD PHARMACEUTICALS INC·Filed 2005·Granted Jun 29, 2010·0 cites·9 claims
- 4262US2005008635A1Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 and their use in pretargeting methodsNEORX CORP·Filed 2004·Application pending·0 cites
- 4362US2011269943A1Radiolabeled annexinsUNIV WASHINGTON·Filed 2010·Application pending·0 cites
- 4461US6075010ASmall molecular weight ligand-hexose containing clearing agentsNEORX CORP·Filed 1994·Granted Jun 13, 2000·24 cites·20 claims
- 4561US4536478AMethod for reducing non-specific interferences in agglutination immunoassaysSERAGAN DIAGNOSTICS INC·Filed 1984·Granted Aug 20, 1985·24 cites·5 claims
- 4659US2003220233A1Radiolabeled annexinsNEORX CORP·Filed 2003·Application pending·0 cites
- 4758US2002137672A1Radiolabeled annexinsFiled 2001·Application pending·0 cites
- 4856US2003119078A1Method of reducing immunogenicity of toxicity of an antibody of IgG classNEORX CORP·Filed 2002·Application pending·0 cites
- 4955US2003099640A1Three-step pretargeting methods and compoundsNEORX CORP·Filed 2002·Application pending·0 cites
- 5054US2014308269A1Humanized antibodiesPERLAN THERAPEUTICS INC·Filed 2013·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →